Parnassus Investments, LLC Abb Vie Inc. Transaction History

Parnassus Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $55.4 Million - $66.6 Million	-880,000 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $53.9 Million - $68.9 Million	-820,000 Reduced 48.24%	880,000 $64 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $131 Million - $154 Million	1,700,000 New	1,700,000 $137 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.